Protective role of 5-lipoxigenase during leishmania infantum infection is associated with th17 subset

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Sacramento, Laís Amorim ^a   Cunha, Fernando Q ^a   De Almeida, Roque Pacheco ^a   Da Silva, João Santana ^a   Carregaro, Vanessa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LEUKOTRIENE B4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; LEISHMANIA INFANTUM; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEUTROPHIL; NONHUMAN; PARASITE CONTROL; PARASITE IMMUNITY; PROTEIN EXPRESSION; REDUCTION; SPLEEN CELL; TARGET ORGAN; TH1 CELL; TH17 CELL; VISCERAL LEISHMANIASIS; ANIMAL; CELL MOTION; DEFICIENCY; DENDRITIC CELL; ENZYMOLOGY; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; MALE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PARASITE; PARASITOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

LEISHMANIA INFANTUM;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; ENZYME ACTIVATION; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MICE; NEUTROPHIL INFILTRATION; PARASITES; PROTECTIVE AGENTS; TH1 CELLS; TH17 CELLS;

EID: 84911883298     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/264270     Document Type: Article

References (68)

1. Thalhofer C. J., Chen Y., Sudan B., Love-Homan L., Wilson M. E., Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan leishmania infantum chagasi. Infection and Immunity 2011 79 1 108 117 10.1128/IAI.00338-10 2-s2.0-78650867910
2. Engwerda C. R., Kaye P. M., Organ-specific immune responses associated with infectious disease. Immunology Today 2000 21 2 73 78 10.1016/S0167-5699(99)01549-2 2-s2.0-0034141801
3. Ghosh K., Sharma G., Saha A., Kar S., Das P. K., Ukil A., Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. Journal of Infectious Diseases 2013 207 6 1016 1025 10.1093/infdis/jis771 2-s2.0-84874253704
4. Antoniazi S., Price H. P., Kropf P., Chemokine gene expression in Toll-like receptor-competent and -deficient mice infected with Leishmania major. Infection and Immunity 2004 72 9 5168 5174 10.1128/IAI.72.9.5168-5174.2004 2-s2.0-4544342028
5. Ritter U., Körner H., Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunology 2002 24 6 295 301 10.1046/j.1365-3024.2002.00467.x 2-s2.0-0036065462
6. Haeggström J. Z., Wetterholm A., Leukotriene Mediators. Transduction Mechanisms in Cellular Signaling: Cell Signaling Collection 2011 349
7. Rinaldo-Matthis A., Haeggström J. Z., Structures and mechanisms of enzymes in the leukotriene cascade. Biochimie 2010 92 6 676 681 10.1016/j.biochi.2010.01.010 2-s2.0-77953293797
8. + T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma. Journal of Allergy and Clinical Immunology 2006 117 3 577 582 10.1016/j.jaci.2005.12.1340 2-s2.0-33644545461
9. Kumar N. S., Schaefer P. A., Lark G., Frieri M., Late phase response during nasal challenge: effect of astemizole on leukotriene B4 levels. Allergy & Asthma Proceedings 1996 17 2 93 99
10. Hashimoto A., Endo H., Hayashi I., Murakami Y., Kitasato H., Kono S., Matsui T., Tanaka S., Nishimura A., Urabe K., Itoman M., Kondo H., Differential expression of leukotriene B4 receptor subtypes (BLT1 and BLT2) in human synovial tissues and synovial fluid leukocytes of patients with rheumatoid arthritis. Journal of Rheumatology 2003 30 8 1712 1718 2-s2.0-0042029641
11. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. H., Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980 286 5770 264 265 10.1038/286264a0 2-s2.0-0019311062
12. Smith M. J. H., Ford-Hutchinson A. W., Bray M. A., Leukotriene B: a potential mediator of inflammation. Journal of Pharmacy and Pharmacology 1980 32 7 517 518 10.1111/j.2042-7158.1980.tb12985.x 2-s2.0-0019142212
13. Flamand L., Borgeat P., Lalonde R., Gosselin J., Release of anti-HIV mediators after administration of leukotriene B4 to humans. Journal of Infectious Diseases 2004 189 11 2001 2009 10.1086/386374 2-s2.0-2542467586
14. 4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent. Viral Immunology 2007 20 3 407 420 10.1089/vim.2006.0099 2-s2.0-35348903449
15. Balamayooran G., Batra S., Balamayooran T., Cai S., Jeyaseelan S., Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infection and Immunity 2011 79 7 2567 2577 10.1128/IAI.00067-11 2-s2.0-79959453402
16. 4 enhances pulmonary host defense against pneumococcal pneumonia. Infection and Immunity 2010 78 5 2264 2271 10.1128/IAI.01323-09 2-s2.0-77951211374
17. Peres C. M., de Paula L., Medeiros A. I., Sorgi C. A., Soares E. G., Carlos D., Peters-Golden M., Silva C. L., Faccioli L. H., Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Microbes and Infection 2007 9 4 483 489 10.1016/j.micinf.2007.01.006 2-s2.0-33947308772
18. Secatto A., Rodrigues L. C., Serezani C. H., Ramos S. G., Dias-Baruffi M., Faccioli L. H., Medeiros A. I., 5-lipoxygenase deficiency impairs innate and adaptive immune responses during fungal infection. PLoS ONE 2012 7 3 e31701 10.1371/journal.pone.0031701 2-s2.0-84858637961
19. Tristão F. S. M., Rocha F. A., Moreira A. P., Cunha F. Q., Rossi M. A., Silvaa J. S., 5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection. Infection and Immunity 2013 81 4 1256 1266 10.1128/IAI.01209-12 2-s2.0-84875529042
20. Santos P. C., Santos D. A., Ribeiro L. S., Fagundes C. T., de Paula T. P., Avila T. V., Baltazar L. D. M., Madeira M. M., Cruz R. D. C., Dias A. C. F., Machado F. S., Teixeira M. M., Cisalpino P. S., Souza D. G., The pivotal role of 5-lipoxygenase-derived LTB4 in controlling pulmonary paracoccidioidomycosis. PLoS Neglected Tropical Diseases 2013 7 8 e2390 10.1371/journal.pntd.0002390 2-s2.0-84883400921
21. Yong E. C., Chi E. Y., Henderson W. R. Jr., Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon γ -induced antitoxoplasma activity. The Journal of Experimental Medicine 1994 180 5 1637 1648 10.1084/jem.180.5.1637 2-s2.0-0027960993
22. Pavanelli W. R., Gutierrez F. R. S., Mariano F. S., Prado C. M., Ferreira B. R., Teixeira M. M., Canetti C., Rossi M. A., Cunha F. Q., Silva J. S., 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes and Infection 2010 12 8-9 587 597 10.1016/j.micinf.2010.03.016 2-s2.0-77954953953
23. 4 amplifies eosinophil accumulation in response to nematodes. The Journal of Experimental Medicine 2014 211 7 1281 1288
24. 4 modulates P2X7 receptor-mediated Leishmania amazonensis elimination in murine macrophages. Journal of Immunology 2014 192 10 4765 4773 10.4049/jimmunol.1301058 2-s2.0-84901258549
25. Tavares N. M., Araújo-Santos T., Afonso L., Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophils. Journal of Infectious Diseases 2014 210 4 656 666 10.1093/infdis/jiu158
26. Serezani C. H., Perrela J. H., Russo M., Peters-Golden M., Jancar S., Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. Journal of Immunology 2006 177 5 3201 3208 10.4049/jimmunol.177.5.3201 2-s2.0-33747809640
27. Reiner N. E., Malemud C. J., Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. Journal of Immunology 1985 134 1 556 563 2-s2.0-0021932176
28. Reiner N. E., Malemud C. J., Arachidonic acid metabolism in murine leishmaniasis (Donovani): Ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cellular Immunology 1984 88 2 501 510 10.1016/0008-8749(84)90181-3 2-s2.0-0021688445
29. Lefèvre L., Lugo-Villarino G., Meunier E., Valentin A., Olagnier D., Authier H., Duval C., Dardenne C., Bernad J., Lemesre J., Auwerx J., Neyrolles O., Pipy B., Coste A., The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity 2013 38 5 1038 1049 10.1016/j.immuni.2013.04.010 2-s2.0-84878203462
30. Carregaro V., Valenzuela J. G., Cunha T. M., Verri W. A. Jr., Grespan R., Matsumura G., Ribeiro J. M. C., Elnaiem D.-E., Silva J. S., Cunha F. Q., Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. Journal of Leukocyte Biology 2008 84 1 104 114 10.1189/jlb.1107797 2-s2.0-46949101198
31. Fan J., Malik A. B., Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nature Medicine 2003 9 3 315 321 10.1038/nm832 2-s2.0-0037351927
32. Sabroe I., Read R. C., Whyte M. K. B., Dockrell D. H., Vogel S. N., Dower S. K., Toll-like receptors in health and disease: complex questions remain. Journal of Immunology 2003 171 4 1630 1635 10.4049/jimmunol.171.4.1630 2-s2.0-0041589513
33. Stockinger B., Veldhoen M., Differentiation and function of Th17 T cells. Current Opinion in Immunology 2007 19 3 281 286 10.1016/j.coi.2007.04.005 2-s2.0-34247555353
34. Peters-Golden M., Brock T. G., Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Letters 2001 487 3 323 326 10.1016/S0014-5793(00)02374-7 2-s2.0-0035808265
35. Beil W. J., Meinardus-Hager G., Neugebauer D.-C., Sorg C., Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. Journal of Leukocyte Biology 1992 52 2 135 142 2-s2.0-0026783507
36. Nauseef W. M., How human neutrophils kill and degrade microbes: an integrated view. Immunological Reviews 2007 219 1 88 102 10.1111/j.1600-065X.2007.00550.x 2-s2.0-34548588559
37. Faurschou M., Borregaard N., Neutrophil granules and secretory vesicles in inflammation. Microbes and Infection 2003 5 14 1317 1327 10.1016/j.micinf.2003.09.008 2-s2.0-0242713072
38. Faurschou M., Sørensen O. E., Johnsen A. H., Askaa J., Borregaard N., Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochimica et Biophysica Acta-Molecular Cell Research 2002 1591 1-3 29 35 10.1016/S0167-4889(02)00243-4 2-s2.0-0037135707
39. Samuelsson B., Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983 220 4597 568 575 10.1126/science.6301011 2-s2.0-0020597565
40. Van Pelt J. P. A., De Jong E. M. G. J., Van Erp P. E. J., Mitchell M. I., Marder P., Spaethe S. M., Van Hooijdonk C. A. E. M., Kuijpers A. L. A., Van De Kerkhof P. C. M., The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111). Biochemical Pharmacology 1997 53 7 1005 1012 10.1016/S0006-2952(96)00884-2 2-s2.0-0030920811
41. H2 cells. Nature Reviews Immunology 2010 10 12 838 848 10.1038/nri2870 2-s2.0-78649516124
42. + myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. The Journal of Immunology 2009 182 1 623 635 10.4049/jimmunol.182.1.623 2-s2.0-59849090484
43. Mancuso P., Nana-Sinkam P., Peters-Golden M., Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infection and Immunity 2001 69 4 2011 2016 10.1128/IAI.69.4.2011-2016.2001 2-s2.0-0034745137
44. Rae S. A., Smith M. J. H., The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4. Journal of Pharmacy and Pharmacology 1981 33 9 616 617 10.1111/j.2042-7158.1981.tb13884.x 2-s2.0-0019407076
45. 4 Molecular Cell Research 1984 803 4 271 277 2-s2.0-0021321871
46. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., Pin J.-J., Garrone P., Garcia E., Saeland S., Blanchard D., Gaillard C., Das Mahapatra B., Rouvier E., Golstein P., Banchereau J., Lebecque S., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. The Journal of Experimental Medicine 1996 183 6 2593 2603 10.1084/jem.183.6.2593 2-s2.0-15844402155
47. Laan M., Cui Z.-H., Hoshino H., Lötvall J., Sjöstrand M., Gruenert D. C., Skoogh B.-E., Lindén A., Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. The Journal of Immunology 1999 162 4 2347 2352 2-s2.0-0033557728
48. Chen H., Qin J., Wei P., Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Prostaglandins Leukotrienes and Essential Fatty Acids 2009 80 4 195 200 10.1016/j.plefa.2009.01.006 2-s2.0-67349189454
49. 4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis. Biochemical and Biophysical Research Communications 2010 394 3 673 678 10.1016/j.bbrc.2010.03.049 2-s2.0-77950521044
50. Rouzer C. A., Shimizu T., Samuelsson B., On the nature of the 5-lipoxygenase reaction in human leukocytes: characterization of a membrane-associated stimulatory factor. Proceedings of the National Academy of Sciences of the United States of America 1985 82 22 7505 7509 10.1073/pnas.82.22.7505 2-s2.0-0345646585
51. Goetzl E. J., Selective feedback inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes. Biochemical and Biophysical Research Communications 1981 101 2 344 350 10.1016/0006-291X(81)91266-3 2-s2.0-0019731392
52. Goodwin J. S., Atluru D., Sierakowski S., Lianos E. A., Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. Journal of Clinical Investigation 1986 77 4 1244 1250 10.1172/JCI112427 2-s2.0-0022549991
53. Balderramas H. A., Human neutrophils produce IL-12, IL-10, PGE2 and LTB4 in response to Paracoccidioides brasiliensis. Involvement of TLR2, mannose receptor and dectin-1. Cytokine 2014 67 1 36 43
54. Conti P., Reale M., Barbacane R. C., Bongrazio M., Panara M. R., Fiore S., Dempsey R., Borish L., Leukocyte inhibitory factor activates human neutrophils and macrophages to release leukotriene B4 and thromboxanes. Cytokine 1990 2 2 142 148 10.1016/1043-4666(90)90008-H 2-s2.0-0025402750
55. Gorak P., Engwerda C. R., Kaye P. M., Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. European Journal of Immunology 1998 28 2 687 695
56. von Stebut E., Belkaid Y., Jakob T., Sacks D. L., Udey M. C., Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti- Leishmania immunity. The Journal of Experimental Medicine 1998 188 8 1547 1552 10.1084/jem.188.8.1547 2-s2.0-0032547859
57. León B., López-Bravo M., Ardavín C., Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007 26 4 519 531 10.1016/j.immuni.2007.01.017 2-s2.0-34247104151
58. Spanbroek R., Stark H.-J., Timmen U. J., Kraft S., Hildner M., Andl T., Bosch F.-X., Fusenig N. E., Bieber T., Rådmark O., Samuelsson B., Habenicht A. J. R., 5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 663 668 10.1073/pnas.95.2.663 2-s2.0-13144257777
59. Spanbroek R., Hildner M., Steinhilber D., Fusenig N., Yoneda K., Radmark O., Samuelsson B., Habenicht A. J. R., 5-Lipoxygenase expression in dendritic cells generated from CD34+ hematopoietic progenitors and in lymphoid organs. Blood 2000 96 12 3857 3865 2-s2.0-0034548833
60. Harizi H., Gualde N., Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells. Prostaglandins Leukotrienes and Essential Fatty Acids 2002 66 5-6 459 466 10.1054/plef.2002.0383 2-s2.0-0036586660
61. Del Prete A., Shao W.-H., Mitola S., Santoro G., Sozzani S., Haribabu B., Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 2007 109 2 626 631 10.1182/blood-2006-02-003665 2-s2.0-33846245411
62. Korn T., Bettelli E., Oukka M., Kuchroo V. K., IL-17 and Th17 cells. Annual Review of Immunology 2009 27 485 517 10.1146/annurev.immunol.021908.132710 2-s2.0-61949463911
63. Aggarwal S., Ghilardi N., Xie M.-H., De Sauvage F. J., Gurney A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry 2003 278 3 1910 1914 10.1074/jbc.M207577200 2-s2.0-0037449737
64. Klickstein L. B., Shapleigh C., Goetzl E. J., Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. Journal of Clinical Investigation 1980 66 5 1166 1170 10.1172/JCI109947 2-s2.0-0019217271
65. Ito S., Ito Y., Katagiri H., Suzuki T., Hoka S., Yokomizo T., Shimizu T., Majima M., Leukotriene b4/leukotriene b4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin. Shock 2008 30 1 87 91 10.1097/SHK.0b013e31815d06a1 2-s2.0-51549093018
66. Serezani C. H., Lewis C., Jancar S., Peters-Golden M., Leukotriene B4 amplifies NF- B activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. The Journal of Clinical Investigation 2011 121 2 671 682 10.1172/JCI43302 2-s2.0-79551526507
67. Muraille E., de Trez C., Brait M., de Baetselier P., Leo O., Carlier Y., Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. Journal of Immunology 2003 170 8 4237 4241 10.4049/jimmunol.170.8.4237 2-s2.0-0037446651
68. de Trez C., Brait M., Leo O., Aebischer T., Torrentera F. A., Carlier Y., Muraille E., Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species. Infection and Immunity 2004 72 2 824 832 10.1128/IAI.72.2.824-832.2004 2-s2.0-0842305635